Resonant Clinical Solutions acquires Creapharm Bioservices

▤ Summary

Resonant Clinical Solutions acquired Creapharm Bioservices to expand its advanced therapy and cryogenic storage capabilities in Europe. The deal strengthens Resonant’s biobanking services for complex clinical programs, including cell and gene therapy trials. Creapharm adds specialized storage, GMP/GDP-compliant handling, and expertise in sensitive biological materials. Resonant said the acquisition supports its strategy to cover more of the clinical lifecycle with global sample management services.

▦ Linked Companies

IQVIA

$1B+